News
The FDA has lifted its hold on Elevidys for ambulatory patients, after asking Sarepta to pause the treatment following three deaths.
Novo Nordisk tapped Maziar Mike Doustdar, its head of international operations, as its new chief executive officer and ...
The Revell family hoped a gene therapy could buy time for their sons, who have a rare and fatal disease. After two patients ...
Detailed price information for Arrowhead Pharma (ARWR-Q) from The Globe and Mail including charting and trades.
US stocks moved higher on Tuesday, eyeing a bid for more records as investors combed through a fresh rush of corporate ...
4d
Pharmaceutical Technology on MSNSarepta refuses to pull gene therapy despite FDA requestSarepta Therapeutics is refusing to pull its gene therapy Elevidys (delandistrogene moxeparvovec), despite a request from the FDA.
Sarepta Therapeutics announces voluntary pause all shipments of Elevidys for Duchenne muscular dystrophy in US: Cambridge, Massachusetts Wednesday, July 23, 2025, 12:00 Hrs [IST] ...
US stocks pared earlier small gains on Tuesday, but kept a bid for more records in play as investors combed through a rush of corporate earnings and economic data key to the odds of interest-rate cuts ...
Most Americans encounter the Federal Trade Commission only if they’ve been scammed: It handles identity theft, fraud, and ...
US stocks gave up earlier gains on Tuesday as investors digested a wave of corporate earnings and economic data, while bracing for the Federal Reserve’s interest rate decision due Wednesday. Traders ...
Welcome to our live blog tracking the latest news and developments from the United States. Stay updated with real-time ...
This regulatory relief, combined with several other compelling catalysts, creates a pathway for the stock to potentially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results